The Nurse View: Targeted Therapies for the Patient With Metastatic
Colorectal Cancer
Targeted Therapies Used in the Treatment of Patients With
mCRC
Case 1: 70-year-old Man With Inoperable mCRC (cont)
Ziv-aflibercept: Potential Side Effects
Ziv-aflibercept: Monitoring for Side Effects
Case 2: 47-year-old Woman With Disease Recurrence Following an Initial Diagnosis of
Stage IIIC Colon Cancer
Regorafenib: Key Patient Education Issues
Regorafinib: Potential Side Effects
Case 2: 47-year-old Woman With mCRC Receiving
Regorafenib
Regorafinib: Monitoring for Side Effects
Hand-Foot Skin Reaction
Strategies for Combating Fatigue
The Importance of Patient Education
Strategies for Prevention and Treatment of HFSR
Hand-Foot Skin Reaction (cont)
Hand-Foot Syndrome vs Hand-Foot Skin Reaction
Summary: Strategies for Optimizing Use of New Targeted
Agents in mCRC
References (cont)
References (cont)